Chemical Properties of Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative

Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative

PDF Excel Molecule Calculator
InChI
InChI=1S/C38H52F6N6O8/c1-21(2)18-28(34(55)58-11)48(8)32(53)27(19-23-20-45(5)25-15-13-12-14-24(23)25)47(7)31(52)26(16-17-29(51)49(9)35(56)37(39,40)41)46(6)33(54)30(22(3)4)50(10)36(57)38(42,43)44/h12-15,20-22,26-28,30H,16-19H2,1-11H3
InChI Key
NCFZVNIXEYBEPL-UHFFFAOYSA-N
Formula
C38H52F6N6O8
SMILES
COC(=O)C(CC(C)C)N(C)C(=O)C(Cc1cn(C)c2ccccc12)N(C)C(=O)C(CCC(=O)N(C)C(=O)C(F)(F)F)N(C)C(=O)C(C(C)C)N(C)C(=O)C(F)(F)F
Molecular Weight1
834.85
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -8.32 Crippen Calculated Property
logPoct/wat 3.794 Crippen Calculated Property
McVol 594.720 ml/mol McGowan Calculated Property
Inp [4282.00; 4363.00]   Show Hide
Inp 4282.00 NIST
Inp 4363.00 NIST

Similar Compounds

Nalmefene. 3-O,6-O,N-Triacetylnormorphine. Benzylmorphine. Nicocodine. Buprenorphine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine. Ergocristine.

Find more compounds similar to Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.